please supply a category in the pcf properties

Journal Publishes Research Review by TTUHSC Pharmacy Investigator

In a focused review to Physiological Reports, Vardan Karamyan, Ph.D., addresses three peptides that could be causing severe COVID-19 complications

Faculty Honored at State of the University & Faculty Award Convocation

During a virtual presentation of the 2021 TTUHSC State of the University & Faculty Award Convocation, faculty members and teams were recognized for excellence in teaching, research, teamwork and more.

TTUHSC’s Phy Seeks Answers for Women With Polycystic Ovary Syndrome

Polycystic Ovary Syndrome (PCOS) is the most common endocrine disorder in reproductive- aged women. It affects at least 10% of women, increasing their risk of obesity, diabetes, heart disease, cancer and infertility. To help improve the health of these women, a research team led by Jennifer Phy, D.O., an associate professor at the Texas Tech University Health Sciences Center (TTUHSC) School of Medicine, developed a new dietary approach to managing the syndrome.

Study Shows a Healthy Heart Can Reduce Ocular Disease

At the Texas Tech University Health Sciences Center (TTUHSC), a research team led by Duke Appiah, Ph.D., an assistant professor and director of the university’s master of public health program, recently completed a study to better understand how LS7 may influence ocular health.

Novel Treatment Offers Relief to Peripheral Artery Disease Patients

PAD is a potentially life-threatening condition caused by the buildup of plaque that narrows and restricts blood flow to the body’s peripheral arteries. Texas Tech Physicians are the first in Texas to take on this new procedure.

Study Suggests Increased Risks for COVID-19 Patients Who Smoke, Vape

Luca Cucullo, Ph.D., and TTUHSC graduate research assistant Sabrina Rahman Archie reviewed the role smoking and vaping may play in the cerebrovascular and neurological dysfunction of those who contract the virus.

TTUHSC Researchers Developing Anti-Viral Drug for COVID-19

Scientists in laboratories across the country and throughout the world are investigating myriad drugs, therapies and vaccines to thwart the COVID-19 spread. One of those scientists is Ted Reid, Ph.D., a professor in the Texas Tech University Health Sciences Center (TTUHSC) Department of Ophthalmology and Visual Sciences who specializes in selenium research.

Study Could Lead to New Scale for Stratifying Neuroblastoma Risk

Results from a study conducted by a research team led by C. Patrick Reynolds, M.D., Ph.D., director of the TTUHSC School of Medicine Cancer Center, may prove to be a landmark in pediatric oncology.

Texas Tech University Health Sciences Center Teams Bring Convalescent Plasma Treatments to West Texas

TTUHSC medical teams from the Panhandle and South Plains recently joined a study led by the Mayo Clinic to use convalescent plasma in severely-ill patients with coronavirus (COVID-19).

TTUHSC Team Decontaminates PPE to Solve Shortages

One suggested way to reduce the stress COVID-19 has placed on the PPE supply chain is to extend the lifetime of existing equipment. With that in mind, a team from TTUHSC has been studying a method that can decontaminate used PPE, especially N95 masks and face shields.

Tags